Altimmune Inc (ALT) Company Profile & Statistics

Altimmune Inc
ALT
(Nasdaq - US)
Closed
8.66
+0.26 (+3.03%)
in:usd•As of: Nov 22, 2024 15:59 UTC -5
Open
8.44
High
8.84
Low
8.30

About Altimmune Inc

CEO

Vipin K. Garg

Headquarters

910 clopper road, suite 201s

gaithersburg, md 20878, united states

Auditor

Ernst & Young LLP

Employees

Share Holders

181

Website

www.altimmune.com

Industry

biotechnology

Sector

health technology

Company Overview

Altimmune, Inc. is a clinical-stage immunotherapeutics company. It focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease. The company's proprietary platform technologies consist of RespirVec and Densigen. Altimmune Inc., formerly known as Pharmathene Inc., is based in Gaithersburg, United States.

Altimmune Inc Statistics

Valuation Measures

Market Capitalization ²	615.90M
Enterprise Value	584.38M
Enterprise Value/EBITDA (ttm)	-5.07
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	4.48
Price to Sales (ttm)	11.50K
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	100.00%
Operating Margin (ttm)	-175194.22%
Profit Margin (ttm)	-380774.05%
Return on Equity (ttm)	-55.81%
Return on Invested Capital (ttm)	-63.69%
Return on Assets (ttm)	-50.60%

Income Statement

Revenue (ttm)	52.00K
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	52.00K
EBITDA (ttm)³	-115.34M
Net Income Avi to Common (ttm)	-103.52M
Diluted EPS (ttm)	-1.55

Share Statistics

Beta (5Y Monthly)	0.09
52-Week Change	229.28%
S&P500 52-Week Change	30.93%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	71.12M
Dividend Yield	0.00%
Float ⁴	68.21M
% Held by Insiders	4.10%
% Held by Institutions	78.05%

Balance Sheet

Total Cash (mrq)	139.42M
Total Cash Per Share (mrq)	1.96
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	16.87%
Quick Ratio (mrq)	16.87%
Book Value Per Share (mrq)	1.88

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.87
Free Cash Flow (ytd)	-61.58M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Altimmune Inc

Trade With A Regulated Broker